Trousseau's syndrome triggered by an immune checkpoint blockade in a non-small cell lung cancer patient
- PMID: 29981156
- DOI: 10.1002/eji.201847645
Trousseau's syndrome triggered by an immune checkpoint blockade in a non-small cell lung cancer patient
Abstract
PD-1 blockade therapy activates T cells by blocking the interaction between PD-1 and PD-L1 and promotes IFN-γ and Th1 cytokine production. In turn, IFN-γ and Th1 cytokines produced by activated T cells promote TF synthesis in monocytes/macrophages, which results in hypercoagulability leading to thrombosis.
Keywords: Immune checkpoint blockade; Immune-related adverse event; Lung cancer; Tissue factor; Trousseau's syndrome.
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
